Literature DB >> 21067174

Determination of the kinetic profile of a dinuclear platinum anticancer complex in the presence of sulfate: introducing a new tool for the expedited analysis of 2D [(1)H,( 15)N] HSQC NMR spectra.

Rasha A Ruhayel1, Ben Corry, Carlos Braun, Donald S Thomas, Susan J Berners-Price, Nicholas P Farrell.   

Abstract

Two-dimensional (2D) [(1)H, (15)N] heteronuclear single-quantum coherence (HSQC) NMR experiments of the kinetics of aquation and sulfation of the dinuclear platinum anticancer complex [{trans-PtCl(NH(3))(2)}(2)(μ-NH(2)(CH(2))(6)NH(2))](2+) (1,1/t,t, 1) in 15 mM sulfate solution are reported using conditions (298 K, pH 5.4) identical to those previously used for other anionic systems (phosphate and acetate), allowing for a direct comparison. Sulfate is the fourth most abundant anion in human plasma. The rate constant for the aquation step (k(H)) is higher than that previously found in the presence of phosphate, but the anation rate constants are similar. The rate constant for sulfate displacement of the aqua ligand (k(L)) is approximately three times higher than that of phosphate, and a further major difference between these two anions is the very high k(-L) for loss of sulfate, suggesting that when formed in plasma the sulfato species will be substitution labile. We also introduce a novel (free) plug-in, '2D NMR analysis', developed for the expedited integration and analysis of 2D [(1)H, (15)N] HSQC NMR spectra. We have found that this plug-in significantly reduces the amount of time taken in the analysis of experiments with no loss to the quality of the data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067174      PMCID: PMC3341403          DOI: 10.1021/ic100576k

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  18 in total

1.  Modification and uptake of a cisplatin carbonato complex by Jurkat cells.

Authors:  Corey R Centerwall; Kirk A Tacka; Deborah J Kerwood; Jerry Goodisman; Bonnie B Toms; Ronald L Dubowy; James C Dabrowiak
Journal:  Mol Pharmacol       Date:  2006-04-21       Impact factor: 4.436

2.  Renal mechanisms for the excretion of inorganic sulfate in man.

Authors:  E L BECKER; H O HEINEMANN; K IGARASHI; J E HODLER; H GERSHBERG
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

Review 3.  Polynuclear platinum drugs.

Authors:  Nicholas Farrell
Journal:  Met Ions Biol Syst       Date:  2004

4.  Cisplatin carbonato complexes. Implications for uptake, antitumor properties, and toxicity.

Authors:  Corey R Centerwall; Jerry Goodisman; Deborah J Kerwood; James C Dabrowiak
Journal:  J Am Chem Soc       Date:  2005-09-21       Impact factor: 15.419

5.  Effects of geometric isomerism in dinuclear platinum antitumor complexes on aquation reactions in the presence of perchlorate, acetate and phosphate.

Authors:  Junyong Zhang; Donald S Thomas; Murray S Davies; Susan J Berners-Price; Nicholas Farrell
Journal:  J Biol Inorg Chem       Date:  2005-11-02       Impact factor: 3.358

Review 6.  The clinical chemistry of inorganic sulfate.

Authors:  D E Cole; J Evrovski
Journal:  Crit Rev Clin Lab Sci       Date:  2000-08       Impact factor: 6.250

7.  Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex.

Authors:  C Sessa; G Capri; L Gianni; F Peccatori; G Grasselli; J Bauer; M Zucchetti; L Viganò; A Gatti; C Minoia; P Liati; S Van den Bosch; A Bernareggi; G Camboni; S Marsoni
Journal:  Ann Oncol       Date:  2000-08       Impact factor: 32.976

8.  Factors affecting DNA-DNA interstrand cross-links in the antiparallel 3'-3' sense: a comparison with the 5'-5' directional isomer.

Authors:  Rasha A Ruhayel; Joseph J Moniodis; Xiaohong Yang; Jana Kasparkova; Viktor Brabec; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2009-09-21       Impact factor: 5.236

9.  Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma.

Authors:  D I Jodrell; T R J Evans; W Steward; D Cameron; J Prendiville; C Aschele; C Noberasco; M Lind; J Carmichael; N Dobbs; G Camboni; B Gatti; F De Braud
Journal:  Eur J Cancer       Date:  2004-08       Impact factor: 9.162

10.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions.

Authors:  M Piotto; V Saudek; V Sklenár
Journal:  J Biomol NMR       Date:  1992-11       Impact factor: 2.835

View more
  6 in total

1.  Competitive formation of both long-range 5'-5' and short-range antiparallel 3'-3' DNA interstrand cross-links by a trinuclear platinum complex on binding to a 10-mer duplex.

Authors:  Rasha A Ruhayel; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2012-11-19       Impact factor: 4.390

2.  Influence of geometric isomerism on the binding of platinum anticancer agents with phospholipids.

Authors:  Anil K Gorle; Junyong Zhang; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2019-07-02       Impact factor: 4.390

3.  Solution studies of dinuclear polyamine-linked platinum-based antitumour complexes.

Authors:  Rasha A Ruhayel; Ibrahim Zgani; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2011-03-08       Impact factor: 4.390

4.  Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism.

Authors:  Brad T Benedetti; Erica J Peterson; Peyman Kabolizadeh; Alberto Martínez; Ralph Kipping; Nicholas P Farrell
Journal:  Mol Pharm       Date:  2011-05-16       Impact factor: 4.939

5.  A new approach to glycan targeting: enzyme inhibition by oligosaccharide metalloshielding.

Authors:  John B Mangrum; Brigitte J Engelmann; Erica J Peterson; John J Ryan; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Commun (Camb)       Date:  2014-04-21       Impact factor: 6.222

6.  Antiangiogenic platinum through glycan targeting.

Authors:  Erica J Peterson; A Gerard Daniel; Samantha J Katner; Lisa Bohlmann; Chih-Wei Chang; Anna Bezos; Christopher R Parish; Mark von Itzstein; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Sci       Date:  2016-08-12       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.